Camden National Corporation’s Thermo Fisher Scientific TMO Stock Holding History

Camden National Corporation’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$3.27M	Buy	+7,177	New	+$3.43M	0.65%	59

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Camden National Corporation's TMO Position: Q1 2021 in Review

Camden National Corporation opened a new position in Thermo Fisher Scientific (TMO) in Q1 2021: 7,177 shares worth $3.27M. The stake represents 0.65% of the portfolio and ranks #59 among its holdings.

2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

Camden National Corporation held 7,177 shares of Thermo Fisher Scientific worth $3.27M as of Q1 2021.
Thermo Fisher Scientific was a new Camden National Corporation position in Q1 2021.
Thermo Fisher Scientific made up 0.65% of Camden National Corporation's portfolio in Q1 2021, its #59 holding.
2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.